Get the Stockscreener App
5.935
0.92%
-0.055
After Hours:
5.99
0.055
+0.93%
Aldeyra Therapeutics Inc Stock (ALDX) Forecast
The Aldeyra Therapeutics Inc (ALDX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $1.3452, representing a -77.33% decrease from the current price of $5.935. The highest analyst price target is $2.3627, and the lowest is $0.3277.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ALDX Price Target
Average 2.8298
(-52.32% Downside)
Is Aldeyra Therapeutics Inc (ALDX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 66.05 | Neutral |
| STOCH(9,6) | 82.49 | Sell |
| STOCHRSI(14) | 82.50 | Sell |
| MACD(12,26) | 0.238 | Buy |
| ADX(14) | 29.39 | Buy |
| William %R | -19.62 | Sell |
| CCI(14) | 91.99 | Neutral |
Buy: 2
Sell: 3
Neutral: 2
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
5.5905
Buy
|
5.6561
Buy
|
| MA20 |
5.279
Buy
|
5.4323
Buy
|
| MA50 |
5.1261
Buy
|
5.2274
Buy
|
| MA100 |
5.2051
Buy
|
5.0946
Buy
|
| MA200 |
4.7372
Buy
|
4.7468
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, ALDX could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 3 signaling Sell signals and 2 Neutral signals. This might be a good time to open fresh positions on ALDX, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 66.05 indicates that ALDX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 82.49 indicates that ALDX is oversold. This means that ALDX price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 82.5 indicates that ALDX is oversold. This suggests that ALDX price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 29.39 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 91.99 indicates that ALDX is still overbought but not to an extreme extent.
Long-term ALDX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Aldeyra Therapeutics Inc financial reports and earnings history, Aldeyra Therapeutics Inc (ALDX) stock could reach $0.5612 by 2030, $4.0112 by 2040 and $9.2153 by 2050. See the projected annual prices until 2050 of the Aldeyra Therapeutics Inc stock below:
- Aldeyra Therapeutics Inc (ALDX) is expected to reach an average price of $1.6491 in 2035, with a high prediction of $2.4539 and a low estimate of $1.7391. This indicates an $-72.21% rise from the last recorded price of $5.935.
- Aldeyra Therapeutics Inc (ALDX) stock is projected to chart a bullish course in 2040, with an average price target of $2.6899, representing an $-54.68% surge from its current level. The forecast ranges from a conservative $2.1199 to a sky-high $4.0112.
- Our analysts predict Aldeyra Therapeutics Inc (ALDX) to jump -23.84% by 2045, soaring from $4.0071 to an average price of $4.5198, potentially reaching $4.1622. While $4.0071 is the low estimate, the potential upside is significant.
- Aldeyra Therapeutics Inc (ALDX) stock is expected to climb by 2050, reaching an average of $8.2993, a $39.84% jump from its current level. However, a wide range of estimates exists, with high and low targets of $9.2153 and $9.4634, respectively, highlighting the market's uncertainty.
Aldeyra Therapeutics Inc Stock (ALDX) Year by Year Forecast
Aldeyra Therapeutics Inc Stock (ALDX) Price Forecast for 2025
Aldeyra Therapeutics Inc Stock (ALDX) is expected to reach an average price of $2.8298 in 2025, with a high prediction of $5.5963 and a low estimate of $0.0634. This indicates an -52.32% fall from the last recorded price of $5.935.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $0.4527 | $0.3277 | $2.3627 | -92.37% |
| April, 2025 | $0.9642 | $0.0634 | $0.7392 | -83.75% |
| May, 2025 | $0.5075 | $0.5118 | $0.9286 | -91.45% |
| June, 2025 | $1.2506 | $0.4494 | $1.5206 | -78.93% |
| July, 2025 | $1.2986 | $0.5418 | $2.0274 | -78.12% |
| August, 2025 | $1.621 | $0.7342 | $2.351 | -72.69% |
| September, 2025 | $3.9534 | $1.4866 | $4.5634 | -33.39% |
| October, 2025 | $2.7014 | $2.3914 | $4.3846 | -54.48% |
| November, 2025 | $4.2839 | $2.3871 | $4.6639 | -27.82% |
| December, 2025 | $3.5819 | $3.1119 | $5.5963 | -39.65% |
Aldeyra Therapeutics Inc Stock (ALDX) Price Forecast for 2026
The predicted value for Aldeyra Therapeutics Inc (ALDX) in 2026 is set at an average of $8.0981. Estimates vary from a peak of $13.01 to a trough of $3.1875, indicating an +36.45% surge from the present price of $5.935.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $3.8643 | $3.1875 | $4.0275 | -34.89% |
| February, 2026 | $4.4767 | $3.5355 | $4.6967 | -24.57% |
| March, 2026 | $10.34 | $3.4335 | $10.57 | +74.21% |
| April, 2026 | $9.7471 | $7.3159 | $11.59 | +64.23% |
| May, 2026 | $8.9995 | $6.9083 | $10.11 | +51.64% |
| June, 2026 | $9.082 | $7.1451 | $9.892 | +53.02% |
| July, 2026 | $9.21 | $7.1732 | $13.01 | +55.18% |
| August, 2026 | $9.4324 | $8.1712 | $10.27 | +58.93% |
| September, 2026 | $7.9004 | $6.9604 | $9.638 | +33.12% |
| October, 2026 | $6.9728 | $5.6172 | $8.0274 | +17.49% |
| November, 2026 | $6.6552 | $5.174 | $7.3384 | +12.14% |
| December, 2026 | $5.9832 | $5.0876 | $6.9808 | +0.81% |
Aldeyra Therapeutics Inc Stock (ALDX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Aldeyra Therapeutics Inc (ALDX) is $3.5059, with a high forecast of $6.9669 and a low forecast of $0.045. This indicates an -40.93% decrease from the last price of $5.935.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $5.2557 | $5.0557 | $6.6045 | -11.45% |
| February, 2027 | $5.1681 | $5.0781 | $6.9669 | -12.92% |
| March, 2027 | $4.3061 | $3.7761 | $5.4937 | -27.45% |
| April, 2027 | $1.0685 | $0.6385 | $4.5317 | -82.00% |
| May, 2027 | $0.8509 | $0.2997 | $1.1909 | -85.66% |
| June, 2027 | $0.8389 | $0.8115 | $1.6015 | -85.86% |
| July, 2027 | $1.8063 | $0.7845 | $2.6713 | -69.56% |
| August, 2027 | $0.9238 | $0.8938 | $2.4126 | -84.44% |
| September, 2027 | $0.5118 | $0.045 | $1.1294 | -91.38% |
| October, 2027 | $0.7842 | $0.283 | $1.4586 | -86.79% |
| November, 2027 | $1.9466 | $0.5198 | $1.9666 | -67.20% |
| December, 2027 | $4.9546 | $1.7222 | $5.4746 | -16.52% |
Aldeyra Therapeutics Inc Stock (ALDX) Price Forecast for 2028
In 2028, Aldeyra Therapeutics Inc (ALDX) is projected to reach an average price of $6.1176, with a high projection of $9.7348 and a low estimate of $2.5004. This indicates an +3.08% rise from the last price of $5.935.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $4.447 | $4.2458 | $5.1502 | -25.07% |
| February, 2028 | $2.8694 | $2.6394 | $4.4143 | -51.65% |
| March, 2028 | $3.0175 | $2.5004 | $3.325 | -49.16% |
| April, 2028 | $3.0399 | $2.5287 | $3.4743 | -48.78% |
| May, 2028 | $4.2079 | $2.7455 | $4.2279 | -29.10% |
| June, 2028 | $3.9503 | $3.6003 | $4.8091 | -33.44% |
| July, 2028 | $3.9727 | $3.3915 | $4.5677 | -33.06% |
| August, 2028 | $4.8607 | $3.8037 | $5.6807 | -18.10% |
| September, 2028 | $7.5931 | $4.5803 | $7.7331 | +27.94% |
| October, 2028 | $8.2956 | $6.68 | $8.5937 | +39.77% |
| November, 2028 | $8.4036 | $6.8724 | $8.4712 | +41.59% |
| December, 2028 | $6.166 | $3.2404 | $9.7348 | +3.89% |
Aldeyra Therapeutics Inc Stock (ALDX) Price Forecast for 2029
The 2029 price forecast for Aldeyra Therapeutics Inc Stock (ALDX) is $3.1679 on average, with a high prediction of $6.2366 and a low estimate of $0.0993. This represents an -46.62% decrease from the previous price of $5.935.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $5.919 | $5.3516 | $6.2366 | -0.27% |
| February, 2029 | $5.4164 | $4.9058 | $6.1896 | -8.74% |
| March, 2029 | $4.3788 | $4.2988 | $5.642 | -26.22% |
| April, 2029 | $3.3012 | $3.0912 | $4.6056 | -44.38% |
| May, 2029 | $0.1843 | $0.0993 | $0.7993 | -96.90% |
| June, 2029 | $0.7817 | $0.1349 | $0.8761 | -86.83% |
| July, 2029 | $1.4541 | $0.6629 | $1.7141 | -75.50% |
| August, 2029 | $1.1021 | $0.9265 | $1.6397 | -81.43% |
| September, 2029 | $1.4845 | $1.0433 | $1.6945 | -74.99% |
| October, 2029 | $0.9225 | $0.7269 | $2.3457 | -84.46% |
| November, 2029 | $1.9049 | $0.8781 | $3.0037 | -67.90% |
| December, 2029 | $0.62 | $0.50 | $2.3567 | -89.55% |
Aldeyra Therapeutics Inc Stock (ALDX) Price Forecast for 2030
Aldeyra Therapeutics Inc Stock (ALDX) is expected to reach an average price of $2.1242 in 2030, with a high forecast of $4.2173 and a low forecast of $0.0312. This signifies an -64.21% decrease from the last price of $5.935.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.584 | $0.0312 | $0.5612 | -90.16% |
| February, 2030 | $1.4491 | $0.7494 | $0.9791 | -75.58% |
| March, 2030 | $1.5643 | $1.6643 | $1.4867 | -73.64% |
| April, 2030 | $2.6045 | $1.9931 | $2.1795 | -56.12% |
| May, 2030 | $1.6635 | $1.3059 | $1.8282 | -71.97% |
| June, 2030 | $1.0686 | $1.3586 | $1.261 | -81.99% |
| July, 2030 | $0.6526 | $1.0126 | $0.7964 | -89.00% |
| August, 2030 | $1.1178 | $0.6014 | $1.329 | -81.17% |
| September, 2030 | $0.4829 | $0.9554 | $0.5942 | -91.86% |
| October, 2030 | $1.5569 | $0.7017 | $1.2219 | -73.77% |
| November, 2030 | $4.1521 | $1.6347 | $3.1421 | -30.04% |
| December, 2030 | $4.6373 | $4.2785 | $4.2173 | -21.87% |
2.27%
5.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):